title: Effect of angiotensin II on cytosolic free calcium in neonatal rat cardiomyocytes.
abstract: The effect of angiotensin II (ANG II) on cytosolic free Ca2+ concentration ([Ca2+]i) was studied in cultured neonatal rat ventricular myocytes. [Ca2+]i was estimated in groups of one to three cells by dual-wavelength microfluorometry or in cell populations using conventional fluorometry. ANG II (10(-8) M) produced an acute short-lived increase over the control basal diastolic [Ca2+]i and increased the frequency of the [Ca2+]i transients. The amplitude of the [Ca2+]i transients was decreased to 64.4% of basal values. The effect of ANG II on [Ca2+]i was blocked by the selective AT1 receptor subtype antagonist Du Pont 753 but not by the AT2 antagonist PD 123319. Removal of extracellular Ca2+ or blockade of voltage-gated Ca2+ channels in cells cultured for 5-7 days abolished the [Ca2+]i transients, but only partially diminished the effect of ANG II on [Ca2+]i. Thapsigargin, an inhibitor of sarcoplasmic reticulum Ca(2+)-Mg(2+)-ATPase, reduced or abolished the [Ca2+]i response to ANG II. Phorbol 12-myristate 13-acetate (PMA), 10(-6) and 10(-7) M, also decreased the amplitude of the Ca2+ transients similar to ANG II. Pretreatment with 10(-6) M PMA or 10(-6) M 1-oleoyl-2-acetyl-glycerol (OAG) inhibited the initial rise in [Ca2+]i and the Ca2+ transients. Thus ANG II produces an acute rise in [Ca2+]i which is derived predominantly from sarcoplasmic reticulum intracellular stores. This acute effect is followed by a significant reduction in the amplitude for the Ca2+ transient and may be mediated by activation of protein kinase C.
authors.affiliation: Department of Medicine, University of Geneva, Switzerland.
authors.forename: D C
authors.initials: DC
authors.lastname: Kem
authors.forename: E I
authors.initials: EI
authors.lastname: Johnson
authors.forename: A M
authors.initials: AM
authors.lastname: Capponi
authors.forename: D
authors.initials: D
authors.lastname: Chardonnens
authors.forename: U
authors.initials: U
authors.lastname: Lang
authors.forename: B
authors.initials: B
authors.lastname: Blondel
authors.forename: H
authors.initials: H
authors.lastname: Koshida
authors.forename: M B
authors.initials: MB
authors.lastname: Vallotton
mesh_terms: D000804:Angiotensin II / Q000502:physiology*; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D000831:Animals, Newborn; D001667:Binding, Competitive; D002118:Calcium / Q000378:metabolism*; D000252:Calcium-Transporting ATPases / Q000037:antagonists & inhibitors; D002478:Cells, Cultured; D003592:Cytophotometry; D003600:Cytosol / Q000378:metabolism*; D009200:Myocardial Contraction; D009206:Myocardium / Q000166:cytology / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D011945:Receptors, Angiotensin / Q000378:metabolism; D013729:Terpenes; D013755:Tetradecanoylphorbol Acetate; D019284:Thapsigargin
chemical_list: D057911:Angiotensin Receptor Antagonists; D011945:Receptors, Angiotensin; D013729:Terpenes; D000804:Angiotensin II; D019284:Thapsigargin; D000252:Calcium-Transporting ATPases; D013755:Tetradecanoylphorbol Acetate; D002118:Calcium